Avricore Health (AVCRF) Non Operating Investment Income (2023 - 2024)
Avricore Health (AVCRF) reported Non Operating Investment Income of -$131264.2 for Q3 2024, up 38.27% year-over-year from -$94934.5 in Q4 2023, and up 38.27% quarter-over-quarter from -$212636.4 in Q3 2023.
Avricore Health (AVCRF) Non Operating Investment Income (2023 - 2024) Analysis & Trends
Avricore Health (AVCRF) has 2 years of Non Operating Investment Income data on file, last reported at -$131264.2 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | - |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | - |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -131,264.21 |
| Sep 30, 2024 | -131,264.21 |
| Sep 30, 2023 | -212,636.43 |
| Sep 30, 2023 | -212,636.43 |